FDA OKs Orencia for Juvenile Arthritis
Links shared publicly online about this topic
UPDATE 1-Bristol-Myers gets FDA ok for subcutaneous Orencia | Reuters
reuters.com — “* Drug will be commercially available in the US in Sept. July 29 (Reuters) - Biopharmaceutical company Bristol-MyersSquibb Co said the U.S. Food and Drug Administrationapproved a subcutaneous” View full resource at reuters.com
Most Recently Shared on July 30, 2011 at 1:34 pm By:
Drugs and Devices OW OW Health
Bristol-Myers gets FDA ok for subcutaneous Orencia - Reuters: RTT NewsBristol-Myers gets FDA ok for subcut... http://bit.ly/qiLwaG #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
